Inventor · disambiguated record
Michael Andreeff
Also filed as: ANDREEFF MICHAEL
5 granted patents·10 pending applications·171 citations·filing 2001–2023
79Inventor score
Files withUNIV TEXAS8ASCENTAGE PHARMA SUZHOU CO LTD1DAIICHI SANKYO CO LTD1DARTMOUTH COLLEGE1MEYER COLIN1
Top patents by PatentIndex Score
15 records- 0195US7795305B2CDDO-compounds and combination therapies thereofUNIV TEXAS·Filed 2008·Granted Sep 14, 2010·57 cites·12 claims
- 0294US7435755B2CDDO-compounds and combination therapies thereofDARTMOUTH COLLEGE·Filed 2001·Granted Oct 14, 2008·111 cites·51 claims
- 0369US6929802B2Method of cancer treatmentUNIV TEXAS·Filed 2003·Granted Aug 16, 2005·3 cites·11 claims
- 0459US2025099440A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0558US7204996B2Method of cancer treatmentUNIV TEXAS·Filed 2005·Granted Apr 17, 2007·0 cites·22 claims
- 0658US2009048205A1Combination therapy with synthetic triterpenoids and gemcitabineMEYER COLIN·Filed 2008·Application pending·0 cites
- 0755US2024238291A1Combinations for treatment of cancerSYNDAX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0853US2025198996A1Extended live cell barcoding approach for multiplexed mass cytometryUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0952US2010173928A1Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complexSABATINI DAVID M·Filed 2008·Application pending·0 cites
- 1050US2023027472A1Targeting p73 for cancers resistant to bh3 mimeticsUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1145US2022143024A1Methods of using imipridonesUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1244US9846160B2Ganglioside GD2 as a marker and target on cancer stem cellsUNIV TEXAS·Filed 2013·Granted Dec 19, 2017·0 cites·13 claims
- 1338US2004076622A1Local production and/or delivery of anti-cancer agents by stromal cell precursorsUNIV TEXAS·Filed 2003·Application pending·0 cites
- 1432US2019125715A1CDDO-Me AS A THERAPY FOR LUPUSMOHAN CHANDRA·Filed 2015·Application pending·0 cites
- 1531US2018303812A1Pharmaceutical composition for use in treating aml and method of treating aml in a subject in need thereofDAIICHI SANKYO CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Andreeff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →